We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Mayne Renews Crusade For Colon Cancer Drug

Law360 (July 23, 2007, 12:00 AM EDT) -- On the heels of several suits Sanofi-Aventis U.S. LLC has launched against generics over the blockbuster cancer drug Eloxatin, Mayne Pharma Ltd. filed a suit for judgment of noninfringement of Sanofi's...
To view the full article, register now.